radpharm leucocyte labelling kit injection composite pack
global medical solutions australia pty limited t/a radpharm scientific - sodium fluoride, quantity: 1 mg/ml - injection, powder for - excipient ingredients: stannous fluoride - indications as at 25 september 1996: technetium (99mtc) labelled leucocytes may be used to image acute inflammation or infection.
iasocholine 1 gbq/ml, solution for injection
iason gmbh feldkirchner str. 4, a-8054 graz, austria - fluorocholine - solution for injection - fluorocholine (18-f) 100 mbq/ml - diagnostic radiopharmaceuticals
iasonfluoride 2 gbq/ml inj. sol. i.v. multidos. cont.
iason labormedizin gmbh & co. kg - sodium fluoride (18 f) 2 gbq/ml - solution for injection - 2 gbq/ml - sodium fluoride (f-18) - sodium fluoride (18f)
iasonfluoride 2 gbq/ml inj. sol. i.v. multidos. cont.
iason labormedizin gmbh & co. kg - sodium fluoride (18 f) 2 gbq/ml - solution for injection - 2 gbq/ml - sodium fluoride (f-18) - sodium fluoride (18f)
calcium gluconate 10% solution for injection 10ml ampoules
hameln pharma ltd - calcium gluconate - solution for injection - 100mg/1ml
addaven concentrated injection ampoule
fresenius kabi australia pty ltd - chromic chloride hexahydrate, quantity: 5.33 microgram/ml; ferric chloride hexahydrate, quantity: 540 microgram/ml; sodium selenite, quantity: 17.29 microgram/ml; sodium fluoride, quantity: 210 microgram/ml; cupric chloride dihydrate, quantity: 102.3 microgram/ml; potassium iodide, quantity: 16.6 microgram/ml; sodium molybdate dihydrate, quantity: 4.85 microgram/ml; manganese chloride tetrahydrate, quantity: 19.79 microgram/ml; zinc chloride, quantity: 1.05 mg/ml - injection, concentrated - excipient ingredients: water for injections; hydrochloric acid; xylitol - to meet basal to moderately increased requirements of trace elements in parenteral nutrition in adults, when either oral or enteral nutrition is inappropriate
sodium fluoride f 18 injection, solution
petnet solutions, inc. - sodium fluoride f-18 (unii: 9l75099x6r) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 200 mci in 1 ml - sodium fluoride f 18 injection is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium fl
pentostam 10g/100ml solution for injection vials
glaxosmithkline uk ltd - sodium stibogluconate - solution for injection - 100mg/1ml
sonovue powder for dispersion for injection 8 microlitresml
dch auriga singapore - sulfur hexafluoride - injection, powder, for solution - 8 microlitres/ml - sulfur hexafluoride 8 microlitres/ml
sodium fluoride f 18- sodium fluoride f 18 injection
global isotopes, llc d/b/a zevacor molecular - fluoride ion f-18 (unii: 4m4we5n2ge) (fluoride ion f-18 - unii:4m4we5n2ge) - fluoride ion f-18 10 mci in 1 ml - sodium fluoride f18 injection, usp is indicated for diagnostic positron emission tomography (pet) imaging of bone to define areas of altered osteogenic activity. none. pregnancy category c any radiopharmaceutical including sodium fluoride f 18 injection has a potential to cause fetal harm. the likelihood of fetal harm depends on the stage of fetal development, and the radionuclide dose. animal reproductive and developmental toxicity studies have not been conducted with sodium fluoride f 18 injection. prior to the administration of sodium fluoride f 18 injection to women of childbearing potential, assess for presence of pregnancy. sodium fluoride f 18 injection should be given to a pregnant woman only if clearly needed. it is not known whether sodium fluoride f 18 injection is excreted into human milk. because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants, a decision should be made whether to interrupt nursing after administration of sodium